Meningitis is one of those illnesses people are aware of in the abstract but often do not fully understand until it affects someone they know. It can progress from the first symptoms to a life-threatening emergency within hours. The ACWY strains, in particular, are the ones most relevant to travellers, university students, and people heading to the Hajj or Umrah pilgrimage.
The MenACWY vaccine offers protection against four of the most serious strains of meningococcal disease: A, C, W, and Y. It is available on the NHS for specific groups and privately for everyone else. This post explains what the vaccine covers, who needs it, and what to expect when you book.
What Is Meningococcal Disease and Why Does the ACWY Strain Matter?
Meningococcal disease is caused by the bacterium Neisseria meningitidis. When it invades the bloodstream or the lining of the brain and spinal cord, it causes two serious conditions: meningitis, which is inflammation of the membranes surrounding the brain, and septicaemia, a form of blood poisoning. Both can be fatal without urgent treatment, and even with treatment, survivors can be left with permanent disabilities including hearing loss, brain damage, and limb loss.
There are several distinct strains of meningococcal bacteria, identified by letters. In the UK, group B has historically been the most common, accounting for the majority of all invasive meningococcal disease cases. But strains W and Y are increasingly relevant, particularly in travellers.
According to UKHSA data published in 2025 covering the 2024/25 epidemiological year, there were 378 confirmed cases of invasive meningococcal disease in England. MenW cases rose sharply to 43 in 2024/25, more than double the 17 cases recorded in 2023/24, with the increase specifically linked to travel to the Middle East. MenY accounted for a further 13 cases. Critically, the same UKHSA report confirms that cases due to these ACWY strains have remained very low in vaccinated age groups, with the MenACWY teenage vaccination programme providing highly effective direct and indirect herd protection since its introduction in 2015. The problem lies with those who fall outside that protected cohort.
What Does the MenACWY Vaccine Cover?
The MenACWY vaccine is a single injection that protects against four strains of the meningococcal bacteria: groups A, C, W, and Y. It works by prompting the immune system to build protective antibodies before any exposure to infection occurs.
One dose provides protection for approximately five years. A booster is recommended after that point for anyone who remains at ongoing risk.
The vaccine does not cover meningococcal group B, which is the most common strain in the UK and is covered by a separate vaccine. Our meningitis B vaccine page has full information on that programme and who it is recommended for.
Who Should Get the MenACWY Vaccine in the UK?
University students and young adults
University students starting their first year in shared accommodation are at significantly higher risk of meningococcal disease than their peers. The UKHSA 2024/25 annual report confirms that all teenage cohorts remain eligible for opportunistic MenACWY vaccination until their 25th birthday, and specifically flags that those entering higher education are at much higher risk than peers of the same age who are not in shared living environments.
The NHS offers the MenACWY vaccine as part of the routine teenage programme, administered in school at around Year 9 or 10. However, UKHSA data from the 2023/24 school year shows coverage of only 72.1% in Year 9 and 73.0% in Year 10. That means more than a quarter of school-age teenagers are not receiving the vaccine through the routine programme, and many are reaching university without it.
If you are a student or parent of a student heading to university and are not certain the vaccine has been received, it is worth checking now rather than waiting.
Travellers to high-risk regions
The meningitis belt, a stretch of sub-Saharan Africa running from Senegal in the west to Ethiopia in the east, sees some of the highest rates of meningococcal disease in the world. Countries in this region including Nigeria, Uganda, Ghana, Sudan, and Cameroon carry particularly elevated risk during the dry season from December to June.
The Middle East also presents significant risk, and the sharp rise in MenW cases in 2024/25 was directly linked to travel to Saudi Arabia for the Umrah pilgrimage. This is consistent with a pattern identified by the UKHSA, CDC, and French public health authorities across multiple countries following the 2024 Umrah season.
Parts of Asia, including India and Nepal, and Central and South American destinations including Peru, Ecuador, and Bolivia, also carry risk. If your travel takes you to any of these regions, vaccination before departure is strongly advised.
Hajj and Umrah pilgrims
The Saudi Arabian government mandates proof of MenACWY vaccination for all pilgrims attending Hajj and Umrah. The vaccine must be administered at least ten days before travel to be valid. If you are planning to travel for pilgrimage, this is not optional: you will need documentation of vaccination. Our Hajj and Umrah vaccination service covers the full requirement, including combined packages for all recommended pilgrimage vaccines.
Adults with certain medical conditions
People who have had their spleen removed, have a damaged spleen, or have certain immune deficiencies are at significantly increased risk from meningococcal disease. The NHS typically offers MenACWY vaccination to these groups, but private access is available for anyone whose GP has not yet arranged it.
Healthcare workers and aid workers
Those working in clinical or community settings in endemic regions, or who may be exposed to confirmed meningococcal cases through their work, should confirm their vaccination status regardless of age.
How Does Meningococcal Disease Present?
The symptoms of meningococcal disease come on rapidly and can be easy to mistake for a severe flu in the early stages. The key warning signs include a stiff neck, severe headache, sensitivity to light, high fever, vomiting, and a rash that does not fade when pressed with a glass. The last of these, sometimes called the tumbler test, is a sign of septicaemia and requires immediate emergency attention.
Confusion, seizures, and cold or mottled skin are signs of severe deterioration. The UKHSA 2024/25 report recorded a case fatality ratio of 8.2% across all confirmed invasive meningococcal disease cases, meaning roughly one in twelve confirmed cases resulted in death. Survivors face a significant risk of permanent complications.
Speed of treatment is the single most important factor in outcomes. If you suspect meningococcal disease in yourself or anyone else, call 999 or go directly to A&E without waiting to see if symptoms resolve.
The MenACWY Vaccine and the NHS: What Is Covered?
The NHS offers the MenACWY vaccine free of charge to the following groups:
Teenagers aged 14 to 18 through the school immunisation programme. Individuals who missed the school dose and are under 25, via their GP surgery. Hajj and Umrah pilgrims in some areas, though availability through NHS GPs varies significantly. Adults with specific medical risk factors, including asplenia and immunodeficiencies.
If you fall outside these categories, or if your GP surgery has a long wait for travel vaccination appointments, the vaccine is available privately through Pharmacy M.
If you are travelling to multiple destinations and need a broader vaccination review, our complete guide to UK travel vaccinations is a useful starting point, covering all major travel vaccine recommendations by region.
What Does the MenACWY Vaccine Cost Privately?
The MenACWY vaccine is available at Pharmacy M for £55 per dose. As a single injection covers the full course, that is the total cost for most people. No GP referral is required, and same-day appointments are available. The price is confirmed upfront before anything is booked.
For context on private vaccination costs and how they compare to NHS provision more broadly, our post on private vs NHS travel vaccinations covers what to expect and when private access makes practical sense.
Timing: When Should You Get Vaccinated?
For most travellers, getting the MenACWY vaccine at least two to three weeks before departure is the standard recommendation, allowing time for immune response to fully develop. For Hajj and Umrah specifically, Saudi Arabia requires the vaccine to have been given at least ten days before arrival.
UKHSA advises consulting a pharmacist, GP, or travel health clinic at least four to six weeks before international travel where multiple vaccines may be needed. This is particularly relevant if you also require hepatitis A, typhoid, or other destination-specific vaccines, which can be given at the same visit.
Our hepatitis A vaccine service and typhoid vaccine service are both available at Pharmacy M for those travelling to regions where all three are recommended.
Frequently Asked Questions
How long does the MenACWY vaccine last?
It provides protection for approximately five years. A booster is recommended after that point for anyone who continues to be at risk, whether through travel, work, or ongoing health conditions.
Is the MenACWY vaccine mandatory for Hajj and Umrah?
Yes. Saudi Arabian authorities require proof of MenACWY vaccination, administered at least ten days before travel, for all pilgrims attending Hajj and Umrah. Without documentation, you will not be permitted entry.
Can students get the MenACWY vaccine on the NHS?
Teenagers who missed the school programme and are under 25 can usually access it through their GP surgery on the NHS. Students who are already over 25, or whose GP cannot offer a timely appointment, can access the vaccine privately at Pharmacy M.
Can I have the MenACWY and MenB vaccines together?
Yes. Both can be given at the same visit, administered in separate arms. If you are unsure which strains you need protection against, our pharmacists can review your circumstances and advise the most appropriate combination.
Is the vaccine suitable for children?
Yes. The MenACWY vaccine is approved for use in children aged two and over.
Are there side effects?
Common side effects are mild and short-lived: soreness or redness at the injection site, a low-grade fever, headache, and fatigue for a day or two. Serious allergic reactions are rare. Let your pharmacist know about any known allergies before vaccination.
Do I need the MenACWY vaccine if I already had the MenC vaccine?
The older MenC vaccine protects only against group C. It does not cover strains A, W, or Y. If you had MenC as a child or teenager and have not subsequently received MenACWY, you do not have full protection against the ACWY strains.
Book Your MenACWY Vaccine at Pharmacy M
Whether you are preparing for travel, heading to university, planning pilgrimage, or simply checking that your vaccination history is complete, our pharmacists can advise and vaccinate in a single appointment. No GP referral needed.
Book your MenACWY vaccine at Pharmacy M directly online, or call us on 01709 252669.
